These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 2339367

  • 1. Antithrombin-III assay without influence of heparin cofactor II.
    Enomoto M, Tanimizu I, Sakuragawa N.
    Thromb Res; 1990 Mar 01; 57(5):729-36. PubMed ID: 2339367
    [Abstract] [Full Text] [Related]

  • 2. Thrombin-based antithrombin assays show overestimation of antithrombin III activity in patients on heparin therapy due to heparin cofactor II influence.
    Bohner J, von Pape KW, Blaurock M.
    Thromb Haemost; 1994 Mar 01; 71(3):280-3. PubMed ID: 8029789
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Antithrombin activity of a fucan sulfate from the brown seaweed Ecklonia kurome.
    Nishino T, Aizu Y, Nagumo T.
    Thromb Res; 1991 Jun 15; 62(6):765-73. PubMed ID: 1926066
    [Abstract] [Full Text] [Related]

  • 5. Comparative studies of heparin cofactor activity toward antithrombin III and heparin cofactor II, and antithrombin III affinity between low molecular weight heparin and unfractionated heparin.
    Shimotori T, Sakuragawa N.
    Semin Thromb Hemost; 1990 Oct 15; 16 Suppl():71-6. PubMed ID: 1962909
    [Abstract] [Full Text] [Related]

  • 6. Assessment of interference by heparin cofactor II in the DuPont aca antithrombin-III assay.
    Hortin GL, Tollefsen DM, Santoro SA.
    Am J Clin Pathol; 1988 Apr 15; 89(4):515-7. PubMed ID: 3354504
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Purification and biological property of heparin cofactor II: activation of heparin cofactor II and antithrombin III by dextran sulfate and various glycosaminoglycans.
    Yamagishi R, Niwa M, Kondo S, Sakuragawa N, Koide T.
    Thromb Res; 1984 Dec 15; 36(6):633-42. PubMed ID: 6084876
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of factor X, factor V and prothrombin activation by the bis(lactobionic acid amide) LW10082.
    Ofosu FA, Fareed J, Smith LM, Anvari N, Hoppensteadt D, Blajchman MA.
    Eur J Biochem; 1992 Jan 15; 203(1-2):121-5. PubMed ID: 1730217
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Progressive chromogenic anti-factor Xa assay and its use in the classification of antithrombin deficiencies.
    Kovács B, Bereczky Z, Selmeczi A, Gindele R, Oláh Z, Kerényi A, Boda Z, Muszbek L.
    Clin Chem Lab Med; 2014 Dec 15; 52(12):1797-806. PubMed ID: 24968404
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Study of low molecular weight heparin effect on the relation between anticoagulant activity and antithrombin III affinity.
    Hamano S, Nishiyama M, Kikuchi S, Komatsu H, Miyata H, Ikeda S, Sakuragawa N.
    Thromb Res; 1992 May 15; 66(4):299-307. PubMed ID: 1329257
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.